ArticleOncotarget2016
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma.
Rong An et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleOncotarget2016
Rong An et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.